AzTrials
AzTrials

Intubation;DifficultNCT03624439

Duble Lumen Intubation

A study testing Standard double-lumen tube and Double-Lumen Tube Vivasight-DL in people with Intubation;Difficult and Intubation; Difficult or Failed, run by Lazarski University at 1 site in Poland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Intrabronal intubation is one of the basic methods of airway protection during cardiac surgery. The use of double-lumen tubes in the implementation of a standard method based on macintosh laryngoscope may cause the prolongation of the procedure especially in the case of difficult airways. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
What is being tested?
Standard double-lumen tube and Double-Lumen Tube Vivasight-DL
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
47 participants
Where
1 sitePoland
Study dates
7 Aug 2018to 30 Jun 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • anesthesiologist or a person in the course of specialization
  • consent voluntary participation in the study

Who cannot join

  • refusal to participate in the study

Trial locations and contacts

1 site in 1 country.

Poland1 site
  • Faculty of Medicine, Lazarski University

    Warsaw, Masovian Voivodeship, 02-662

Other trials in Poland

About this study

Official title: Evaluation of the Double-Lumen Tube Vivasight-DL vs. Standard Duble-lumen Tube in Normal and Difficult Airway Scenarios: A Prospective, Randomized, Crossover, Simulation Trial

Intrabronal intubation is one of the basic methods of airway protection during cardiac surgery. The use of double-lumen tubes in the implementation of a standard method based on macintosh laryngoscope may cause the prolongation of the procedure especially in the case of difficult airways. The aim of the study was to match the effectiveness of endotracheal intubation using a standard Macontosh laryngskop and a normal double-lumen tube versus the ETView DL tube.

Being tested
Standard double-lumen tube, Double-Lumen Tube Vivasight-DL
Keywords
double-lumen tube, ETView, medical simulation, anesthesiologist, difficult airway

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Standard double-lumen tubeDevice

    intubation using standard double-lumen tube with Macintosh laryngoscope

  • Double-Lumen Tube Vivasight-DLDevice

    intubation using Double-Lumen Video Tube Vivasight-DL with Macintosh laryngoscope

Study groups in NCT03624439
Study groupRoleWhat they receive
Normal airwayExperimentalnormal airway. the language has not been inflated. the instructor assessed the difficulty of intubation based on the Cormack - Lehane scale to the first degree
Receives: Device: Standard double-lumen tube; Device: Double-Lumen Tube Vivasight-DL
Difficult airwayExperimentaldofficult airway. Difficult airways were obtained by means of language inflation using a simulator control panel, so as to obtain the degree of intubation difficulty assessed by an independent anesthesiologist to the third degree according to the Cormack-Lehane scale
Receives: Device: Standard double-lumen tube; Device: Double-Lumen Tube Vivasight-DL

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. intubation time

    from taking of the intubation device to successful intubation

    Measured: 1 day

Secondary outcomes (6)
  1. time to visualize the glottis

    time defined as the time from taking laryngoscope in hand until you obtain visualize the glottis

    Measured: 1 day

  2. success of the first intubation trial

    effectiveness of the first attempt of intubation by participants using four intubation devices

    Measured: 1 day

  3. overall success rate

    effectiveness measured during a maximum of three intubation attempts, confirmed by a single lung ventilation test

    Measured: 1 day

  4. the degree of visibility of the glottis

    The POGO score describes how much glottic opening is visible. A POGO score of 100% indicates visualization of the entire glottic opening from the anterior commissure of the vocal cords to the interarytenoid notch. A POGO score of 0% corresponds with no visualization of laryngeal structures.

    Measured: 1 day

  5. Cormack - Lehane grade

    self-reported percentage the vocal cord visualization using the Cormack-Lehane grading (grade 1-4)

    Measured: 1 day

  6. ease of use

    To access subjective opinions about the difficulty of the each intubation method, participants were asked to give a rating on a visual analogue scale (VAS) with a score from 1 (extremely easy) to 100 (extremely difficult).

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Aug 2018
  2. Study start7 Aug 2018
  3. Primary completion30 Jun 2019
  4. Study completion30 Jun 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
47 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03624439
Sponsor's protocol ID
ETI_2018_DL1
Status last verified
Jul 2019
First submitted
7 Aug 2018
Last updated
31 Jul 2019
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: The datasets used and/or analyzed during the current study available from the corresponding author on request.

Publications

  • Bialka S, Copik M, Rybczyk K, Owczarek A, Jedrusik E, Czyzewski D, Filipowski M, Rivas E, Ruetzler K, Szarpak L, Misiolek H. Assessment of changes of regional ventilation distribution in the lung tissue depending on the driving pressure applied during high frequency jet ventilation. BMC Anesthesiol. 2018 Jul 31;18(1):101. doi: 10.1186/s12871-018-0552-2.

    PubMed 30064377
  • Szarpak L, Kurowski A, Zasko P, Karczewska K, Czyzewski L, Bogdanski L, Adamczyk P, Truszewski Z. Double-lumen tube tracheal intubation in a manikin model using the VivaSight Double Lumen: a randomized controlled comparison with the Macintosh laryngoscope. Am J Emerg Med. 2016 Jan;34(1):103-4. doi: 10.1016/j.ajem.2015.10.018. Epub 2015 Oct 23. No abstract available.

    PubMed 26527175

Questions about this trial

What is this clinical trial studying?

A study testing Standard double-lumen tube and Double-Lumen Tube Vivasight-DL in people with Intubation;Difficult and Intubation; Difficult or Failed, run by Lazarski University at 1 site in Poland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Jul 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Poland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

intubation time (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03624439, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jul 2019.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in